Analyze Diet

Topic:Medication

The topic of medication in horses encompasses the study and application of pharmaceutical substances used to treat, manage, or prevent diseases and conditions in equine patients. This field involves understanding the pharmacokinetics and pharmacodynamics of various drugs, including their absorption, distribution, metabolism, and excretion in horses. Medications commonly administered to horses include non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, anthelmintics, and sedatives. The appropriate use of these medications is critical for ensuring therapeutic efficacy and minimizing adverse effects. Research in this area focuses on dosage optimization, drug interactions, resistance development, and withdrawal times to ensure both the health of the horse and compliance with regulatory standards. This page aggregates peer-reviewed studies and scholarly articles that explore the pharmacological aspects, clinical applications, and regulatory considerations of equine medications.
In vitro evidence for effects of magnesium supplementation on quinolone-treated horse and dog chondrocytes.
Veterinary pathology    March 31, 2001   Volume 38, Issue 2 143-148 doi: 10.1354/vp.38-2-143
Egerbacher M, Wolfesberger B, Gabler C.Quinolones and magnesium deficiency cause similar lesions in joint cartilage of young animals. Chondrocytes cultivated in the presence of quinolones and in Mg-free medium show severe alterations in cytoskeleton and decreased ability to adhere to the culture dish. We investigated whether Mg2+ supplementation can prevent quinolone-mediated effects on chondrocytes in vitro. Chondrocytes cultivated in Dulbecco's modified Eagle's medium/HAM's F-12 medium were treated with ciprofloxacin (80 and 160 microg/ml) and enrofloxacin (100 and 150 microg/ml). Mg2+ was added at a concentration of 0.0612 mg/ml...
The use of psychoactive agents in veterinary medicine.
International journal of pharmaceutical compounding    March 1, 2001   Volume 5, Issue 2 86-88 
Simpson BS.Psychotropic drugs are used by veterinary behavior specialists and general veterinary practitioners to treat behavior problems of companion animals. Dogs, cats, pet birds, horses, and zoo animals benefit from this type of therapy. However, many drugs used to treat anxiety or depression in animals were designed for use in human patients. Compounding is a critical step in adapting those medications for use in different species. Formulations that improve palatability or facilitate administration can often determine the success or failure of therapy in veterinary patients, and compounding is often...
Pharmacokinetics of metronidazole in horses after intravenous, rectal and oral administration.
Journal of veterinary pharmacology and therapeutics    February 13, 2001   Volume 23, Issue 6 353-357 doi: 10.1046/j.1365-2885.2000.00294.x
Steinman A, Gips M, Lavy E, Sinay I, Soback S.Metronidazole pharmacokinetics in horses was studied after intravenous (i.v.), rectal (p.r.) and oral (p.o.) administration at 20 mg/kg using a triple crossover study design. Metronidazole mean+/-SD half-life was 196+/-39, 212+/-30 and 240+/-65 min after i.v., p.r. and p.o. administration, respectively. The metronidazole clearance was 2.8 (mL/min/kg) and the volume of distribution at steady state was 0.68 L/kg. The pharmacokinetic parameters calculated for metronidazole after administration of the drug by the various routes showed that bioavailability (74+/-18 vs. 30+/-9%) and maximum serum co...
Induction of mucosal and systemic antibody specific for SeMF3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system.
Vaccine    October 12, 2000   Volume 19, Issue 4-5 492-497 doi: 10.1016/s0264-410x(00)00187-0
Nally JE, Artiushin S, Sheoran AS, Burns PJ, Simon B, Gilley RM, Gibson J, Sullivan S, Timoney JF.Streptococcus equi causes equine strangles, a highly contagious disease of the upper respiratory tract. The antiphagocytic surface protein SeM is strongly immunogenic and evokes mucosal and systemic antibodies during convalescence. The present study investigated the potential of sucrose acetate isobutyrate (SAIB); a high viscosity excipient that provides controlled release of biologically active substances, to enhance antibody responses following intranasal immunization of horses with a 108 a.a. peptide of SeM (SeMF3). SeMF3-SAIB was administered intranasally to each of the 11 adult horses on ...
[Veterinary drug profile of Equest].
Tijdschrift voor diergeneeskunde    July 25, 2000   Volume 125, Issue 8 258-261 
van Turnhout J, Boersema J, Pellicaan C.No abstract available
Retail sale of equine medicines.
The Veterinary record    July 20, 2000   Volume 146, Issue 25 739 
Greet T, Jones R.No abstract available
Questions duration of treatment with phenylbutazone.
American journal of veterinary research    July 15, 2000   Volume 61, Issue 7 728 doi: 10.2460/ajvr.2000.61.728
Reilly FK.No abstract available
Pharmacokinetics of a long-acting oxytetracycline-polyethylene glycol formulation in horses.
Journal of veterinary pharmacology and therapeutics    June 10, 2000   Volume 23, Issue 2 107-110 doi: 10.1046/j.1365-2885.2000.00249.x
Dowling PM, Russell AM.No abstract available
Pulmonary vascular pressures of thoroughbred horses exercised 1, 2, 3 and 4 h after furosemide administration.
Journal of veterinary pharmacology and therapeutics    June 10, 2000   Volume 23, Issue 2 81-89 doi: 10.1046/j.1365-2885.2000.00252.x
Magid JH, Manohar M, Goetz TE, Baker GJ, Ulbricht R, Bontkowski S, Ghantous S.Furosemide premedication of horses 4 h prior to exercise significantly attenuates exercise-induced pulmonary capillary hypertension which may help diminish the severity of exercise-induced pulmonary haemorrhage. As pulmonary hemodynamic effects of furosemide may be mediated via a reduction in plasma volume (which is most pronounced 15-30 min postfurosemide administration, with plasma volume recovering thereafter), we hypothesized that administration of furosemide at intervals shorter than 4 h before exertion may be more effective in attenuating the exercise-induced rise in pulmonary capillary ...
Only horses and fools.
European child & adolescent psychiatry    May 5, 2000   Volume 9, Issue 1 66-69 doi: 10.1007/s007870050118
Taylor D.Narrative format, in the form of an invented short story, is used to convey several essential truths in a didactic essay in Neuropsychiatry. Messages, in memorable form, emerge at several levels. Narrative format is essential in biographical medicine and it could be attractive to students at various levels of learning. There are great values and some dangers in biographical science.
Strongyle resistance to fenbendazole in horses.
The Canadian veterinary journal = La revue veterinaire canadienne    April 19, 2000   Volume 41, Issue 4 268 
Authier S.No abstract available
Isoxsuprine: more questions than answers.
Equine veterinary journal    April 1, 2000   Volume 32, Issue 2 90-91 doi: 10.2746/042516400777591507
Elliott J.No abstract available
A review of medical treatment for peptic ulcer disease.
Equine veterinary journal. Supplement    March 4, 2000   Issue 29 45-49 doi: 10.1111/j.2042-3306.1999.tb05168.x
MacAllister CG.No abstract available
Efficacy of omeprazole paste in the treatment and prevention of gastric ulcers in horses.
Equine veterinary journal. Supplement    March 4, 2000   Issue 29 81-86 doi: 10.1111/j.2042-3306.1999.tb05176.x
Andrews FM, Sifferman RL, Bernard W, Hughes FE, Holste JE, Daurio CP, Alva R, Cox JL.Equine gastric ulcer syndrome (EGUS) is very common among performance horses, with a reported prevalence of approximately 90% in racehorses, and also > 50% in foals. Omeprazole, an acid pump inhibitor 5 times more potent than ranitidine, has been used with great success to treat EGUS. This multicentre study of Thoroughbred racehorses with endoscopically verified gastric ulcers was designed to demonstrate the efficacy of an equine oral paste formulation of omeprazole in the treatment and prevention of recurrence of EGUS. Of the 100 horses entered into the study, 25 were sham-dosed for the fu...
Clinical trial to determine the effect of omeprazole given once or twice daily on gastric ulceration.
Equine veterinary journal. Supplement    March 4, 2000   Issue 29 87-90 doi: 10.1111/j.2042-3306.1999.tb05177.x
Vatistas NJ, Nieto JE, Snyder JR, Thompson D.No abstract available
Effects of omeprazole paste on healing of spontaneous gastric ulcers in horses and foals: a field trial.
Equine veterinary journal. Supplement    March 4, 2000   Issue 29 77-80 doi: 10.1111/j.2042-3306.1999.tb05175.x
MacAllister CG, Sifferman RL, McClure SR, White GW, Vatistas NJ, Holste JE, Ericcson GF, Cox JL.A multicentre, blinded, randomised complete-block, field trial was conducted with 140 horses and foals age 4 weeks-28 years to determine if omeprazole paste is effective and safe in promoting healing of spontaneous gastric ulcers under a variety of field conditions and in different breeds and ages of horses. Horses in the study had gastric ulceration as determined by gastroscopy and were divided into replicates of 4 or 5 animals. One horse in each replicate was assigned randomly to receive an empty omeprazole syringe (sham-dosed control) and the remaining horses received omeprazole paste once ...
Effect of omeprazole paste on gastric acid secretion in horses.
Equine veterinary journal. Supplement    March 4, 2000   Issue 29 59-62 doi: 10.1111/j.2042-3306.1999.tb05171.x
Daurio CP, Holste JE, Andrews FM, Merritt AM, Blackford JT, Dolz F, Thompson DR.In a multicentre trial, 13 cannulated horses were treated orally once daily with a paste that delivered omeprazole at a dose of 4 and 5 mg/kg bwt in a 2-period crossover design to evaluate steady state gastric acid suppression. In each period, basal (unstimulated) and pentagastrin-stimulated gastric output were evaluated at 5-8 h after 5 doses, at 13-16 h after 10 doses, and at 21-24 h after 15 doses. Baseline data for gastric acid secretion were collected once for each horse in the month prior to initiation of omeprazole treatment. The inhibition of gastric acid secretion relative to baseline...
Availability of equine medicines.
The Veterinary record    February 8, 2000   Volume 146, Issue 1 27-28 
Jones R, Greet T.No abstract available
Measurements of reproductive function in stallions treated with trimethoprim-sulfamethoxazole and pyrimethamine.
Journal of the American Veterinary Medical Association    December 20, 1999   Volume 215, Issue 9 1317-1319 
Bedford SJ, McDonnell SM.To evaluate the effects of trimethoprim-sulfamethoxazole and pyrimethamine treatment on various measures of reproductive function in healthy pony stallions. Methods: Randomized complete block study. Methods: 12 healthy, mature pony stallions. Methods: Stallions were assigned to treatment and control groups balanced for age and various characteristics of reproductive function. The treated group received trimethoprim-sulfamethoxazole and pyrimethamine for 90 days during summer and fall; the control group was not treated. Semen characteristics, sexual behavior, testicular volume, and sperm produc...
Treatment and control of gastrointestinal parasites.
The Veterinary clinics of North America. Equine practice    December 10, 1999   Volume 15, Issue 3 561-viii doi: 10.1016/s0749-0739(17)30132-3
Hutchens DE, Paul AJ, DiPietro JA.Routine anthelmintic treatments are one of the most important components of an equine wellness program used by horse owners and veterinarians today. Thirteen different compounds are available in the United States in the treatment of gastrointestinal parasites, most of which are available over the counter. As a result, there is a decreased reliance on the veterinarian to perform routine tube dewormings. Therefore, the future of the veterinarian's role in the management of gastrointestinal parasites is likely to be in the consultation and design of parasite control programs. With this in mind, t...
Formulary of common equine drugs.
The Veterinary clinics of North America. Equine practice    December 10, 1999   Volume 15, Issue 3 747-xi doi: 10.1016/s0749-0739(17)30142-6
Whittem T.This article presents in easily accessible form a collection of drug names and dose rates for the drugs recommended or referred to by the authors of the individual articles in this issue. Although the formulary provides recommendations for drug use, the reader is cautioned that the responsibility for the choice of agent, formulation, dose, and dose interval lies with the clinician. The author also addresses regulations that govern the use of drugs in competition horses.
Therapeutics of musculoskeletal disease in the horse.
The Veterinary clinics of North America. Equine practice    December 10, 1999   Volume 15, Issue 3 589-602 doi: 10.1016/s0749-0739(17)30134-7
Kollias-Baker C.Therapeutic medications play a crucial role in the successful therapy of many musculoskeletal diseases that occur in horses. For example, appropriate antibiotic therapy is extremely important in the treatment of diseases caused by infections with microorganisms such as botulism, tetanus, osteomyelitis, and muscle abscesses. In addition, numerous prescription medications and nutritional supplements are available for the treatment of osteoarthritis in horses. Many of these agents currently on the market fall into a new class of drugs called SADMO agents. Unfortunately, the efficacy and mechanism...
Use of unlicensed medicines.
The Veterinary record    October 26, 1999   Volume 145, Issue 12 352 
Keith NW.No abstract available
BERNA: a century of immunobiological innovation.
Vaccine    October 3, 1999   Volume 17 Suppl 2 S1-S5 doi: 10.1016/s0264-410x(99)00228-5
Cryz SJ.At the time the Swiss Serum and Vaccine Institute Berne (BERNA) was found in 1898, few vaccines or immune globulins were available. This short list included vaccines against cholera, typhoid fever, plague, smallpox and rabies and equine anti-tetanus and diphtheria immune globulins. Furthermore, their use was restricted due to limited production capacity, uncertainty regarding safety and no public health infrastructure to promote their utilization. Today, safe and effective vaccines exist for more than 30 infectious diseases while human hyperimmune globulins exist to treat or prevent rabies, te...
Subconjunctivally implanted micro-osmotic pumps for continuous ocular treatment in horses.
American journal of veterinary research    September 18, 1999   Volume 60, Issue 9 1102-1105 
Blair MJ, Gionfriddo JR, Polazzi LM, Sojka JE, Pfaff AM, Bingaman DP.To evaluate the feasibility of using a subconjunctivally implanted micro-osmotic pump for continuous delivery of medication to the eyes of horses- during a 7-day period. Methods: 4 healthy adult horses. Methods: With horses restrained in a standing position, micro-osmotic pumps were implanted subconjunctivally in each eye for 7 days. The treatment eye received an atropine-loaded micro-osmotic pump (100 microl of 1.5% atropine), and the contralateral eye received a sterile saline-loaded pump (100 microl of 0.9% NaCl) as a control treatment. Pupil size was measured at 12-hour intervals until val...
Historical perspective of cyathostomes: prevalence, treatment and control programs.
Veterinary parasitology    September 15, 1999   Volume 85, Issue 2-3 97-225 doi: 10.1016/s0304-4017(99)00091-6
Lyons ET, Tolliver SC, Drudge JH.Small strongyles are highly prevalent in horses and can be found worldwide. Even though over 50 species of these parasites have been described, about 10 species comprise the bulk of the total number present in horses. Efforts to control small strongyles and other equine internal parasites have been undertaken for many years. Some of the early medications and control measures provided questionable activity against endoparasites; whether effective or not, they could be detrimental to the horse. Beginning in the early 1900s, scientific effort was used to evaluate activity of antiparasitic compoun...
Testing for therapeutic medications: analytical/pharmacological relationships and limitations’ on the sensitivity of testing for certain agents.
Journal of veterinary pharmacology and therapeutics    August 14, 1999   Volume 22, Issue 3 220-233 doi: 10.1046/j.1365-2885.1999.00207.x
Tobin T, Harkins JD, Sams RA.Proper veterinary care of horses requires that horses in training have access to modern therapeutic medication. However, the sensitivity of equine drug testing now allows for detection of pharmacologically insignificant concentrations of many therapeutic medications. In 1995, the Association of Racing Commissioners International (ARCI) resolved that members 'address trace level detection so as not to lead to disciplinary action based on pharmacologically insignificant traces of these substances'. The rationale behind this approach is to prevent overly-sensitive testing from inhibiting the prop...
The elimination profiles of oxaprozin in equine urine and serum after a 4.8-g dose.
Journal of analytical toxicology    August 13, 1999   Volume 23, Issue 4 242-246 doi: 10.1093/jat/23.4.242
Marland A, Sarkar P, Leavitt R, Lee-Ruff E, Ramnauth J.A method for the extraction of oxaprozin from equine urine and serum and its quantitation by high-performance liquid chromatography-ultraviolet detection is presented. Confirmation of oxaprozin in postadministration extracts was accomplished by gas chromatographic- mass spectrometric analysis of methylated extracts or liquid chromatography with tandem mass spectrometry daughter ion mass spectra of underivatized extracts. Daypro, a formulation of oxaprozin, was administered orally at a dose of 4.8 g to four standardbred mares. Urine and serum samples were collected to 120 h postadministration. ...
The effect of oral isoxsuprine and pentoxifylline on digital and laminar blood flow in healthy horses.
Veterinary surgery : VS    May 25, 1999   Volume 28, Issue 3 154-160 doi: 10.1053/jvet.1999.0154
Ingle-Fehr JE, Baxter GM.To quantitate blood flow in the palmar digital artery and dorsal laminae of the hoof in standing, unmedicated, nonsedated horses, and in horses treated with oral isoxsuprine, oral pentoxifylline, and intravenous acetylpromazine as a positive control. Methods: Experimental study; treatments administered in a random cross-over design. Methods: A total of 6 healthy horses selected with at least one nonpigmented forelimb hoof wall and determined to be free of laminitis. Methods: All horses were instrumented with a flow probe placed around one palmar digital artery under general anesthesia and a la...
Detomidine-propofol anesthesia for abdominal surgery in horses.
Veterinary surgery : VS    May 25, 1999   Volume 28, Issue 3 196-201 doi: 10.1053/jvet.1999.0196
Matthews NS, Hartsfield SM, Hague B, Carroll GL, Short CE.To evaluate propofol for induction and maintenance of anesthesia, after detomidine premedication, in horses undergoing abdominal surgery for creation of an experimental intestinal adhesion model. Methods: Prospective study. Methods: Twelve horses (424 +/- 81 kg) from 1 to 20 years of age (5 females, 7 males). Methods: Horses were premedicated with detomidine (0.015 mg/kg i.v.) 20 to 25 minutes before induction, and a propofol bolus (2 mg/kg i.v.) was administered for induction. Propofol infusion (0.2 mg/kg/min i.v.) was used to maintain anesthesia. The infusion rate was adjusted to maintain an...
1 … 17 18 19 20 21 … 42